communic
respiratori
infect
import
caus
mortal
morbid
result
healthcar
cost
worth
billion
persontoperson
transmiss
respiratori
pathogen
may
occur
three
key
rout
contact
transmiss
infecti
respiratori
secret
spread
direct
contact
indirectli
contamin
intermedi
object
person
droplet
transmiss
larg
infecti
droplet
travel
directli
short
distanc
respiratori
tract
deposit
onto
mucos
surfac
eg
nasal
conjunctiv
mucou
membran
airborn
transmiss
involv
dissemin
small
droplet
nuclei
within
respir
size
rang
remain
infecti
time
distanc
inhal
suscept
airborn
transmiss
may
pose
signific
risk
hospitalacquir
respiratori
evid
import
mode
acquisit
mani
respiratori
infect
includ
mycobacterium
tuberculosi
tb
bordetella
cystic
fibrosi
cf
common
lifelimit
autosomalrecess
disord
caucasian
affect
person
die
thirdtofourth
decad
respiratori
failur
complic
chronic
pulmonari
pseudomona
aeruginosa
common
pathogen
cf
lung
diseas
infect
establish
acceler
declin
lung
function
qualiti
life
mani
patient
cf
acquir
p
aeruginosa
sporad
environ
moleculartyp
studi
show
share
strain
common
cf
centr
suggest
persontoperson
transmiss
may
also
australia
p
aeruginosa
strain
respons
chronic
associ
wors
clinic
outcom
increas
treatment
mechan
crossinfect
cf
unknown
howev
despit
cf
centr
implement
contact
droplet
transmiss
control
measur
p
aeruginosa
crossinfect
interrupt
implement
strict
patient
segreg
seem
plausibl
mechan
transmiss
patient
airborn
rout
inde
patient
cf
infect
p
aeruginosa
produc
droplet
nuclei
contain
viabl
furthermor
studi
use
air
sampl
cf
clinic
set
demonstr
viabl
p
aeruginosa
physiotherapi
corridor
outsid
inpati
cubicl
room
hous
patient
share
strain
p
aeruginosa
other
also
suggest
airborn
transmiss
feasibl
share
mucoid
p
aeruginosa
strain
surviv
howev
method
use
previou
studi
unabl
demonstr
long
viabl
bacteria
present
aerosol
far
could
travel
origin
sourc
therefor
sought
enhanc
understand
p
aeruginosa
aerosol
product
cf
order
determin
durat
distanc
viabl
cough
aerosol
ii
identifi
factor
influenc
pathogen
viabil
iii
understand
effect
room
ventil
control
durat
viabl
airborn
p
aeruginosa
patient
cf
age
year
old
chronic
infect
p
aeruginosa
recruit
royal
children
hospit
rch
princ
charl
hospit
tpch
brisban
australia
exclus
criteria
includ
recent
pneumothorax
haemoptysi
pregnanc
healthi
nonsmok
control
recruit
hospit
staff
famili
detail
provid
onlin
supplementari
method
rch
univers
queensland
queensland
univers
technolog
human
research
ethic
committe
approv
studi
particip
guardian
provid
written
inform
consent
subject
attend
two
studi
day
separ
mean
sd
day
rang
sputum
sampl
collect
patient
cf
day
test
cough
manoeuvr
supervis
healthcar
profession
emerg
equip
avail
forc
expiratori
volum
onesecond
forc
vital
capac
fvc
measur
subject
accord
atser
respiratori
muscl
strength
measur
maximum
inspiratori
mip
maximum
expiratori
mep
mouth
pressur
use
micro
medic
respiratori
pressur
meter
tpch
weight
height
age
sex
clinic
statu
exacerb
clinic
stabl
record
distanc
rig
see
onlin
supplementari
method
permit
measur
cough
aerosol
particlefre
environ
distanc
subject
see
onlin
supplementari
figur
andersen
impactor
lmin
captur
measur
viabl
cough
aerosol
lasair
optic
particl
counter
opc
measur
realtim
particl
concentr
verifi
absenc
room
air
aerosol
contamin
distanc
rig
andersen
impactor
opc
sampl
collect
common
circular
isokinet
inlet
subject
sat
head
rig
breath
higheffici
particul
air
hepa
filter
air
min
purg
residu
room
air
lung
cough
frequent
strongli
comfort
min
andersen
impactor
sampl
continu
voluntari
cough
phase
cough
number
record
manual
cough
aerosol
collect
order
randomis
subject
perform
duplic
cough
manoeuvr
distanc
durat
rig
see
onlin
supplementari
method
compris
airtight
stainless
steel
cylind
illustr
onlin
supplementari
figur
assess
durat
aerosol
particl
viabil
airborn
phase
cylind
rotat
rpm
gravit
settl
inerti
impact
particl
system
flush
hepafilt
air
sampl
collect
cough
aerosol
contamin
room
air
aerosol
subject
seat
fit
snorkelstyl
mouthpiec
carefus
australia
connect
cm
flexibl
tube
nose
clip
attach
subject
breath
filter
air
min
cough
much
comfort
min
cough
number
record
manual
rig
isol
result
cough
aerosol
age
min
suspend
particl
collect
andersen
impactor
conclus
age
period
measur
min
age
perform
duplic
logist
reason
one
measur
perform
min
age
cough
aerosol
cultur
perform
chocol
bacitracin
mgml
agar
use
previous
describ
incub
condit
colonyform
unit
cfu
count
quantit
sputum
qualit
cultur
perform
respiratori
sampl
use
standard
techniqu
presumpt
screen
p
aeruginosa
isol
confirm
duplex
realtim
rt
pcr
p
aeruginosa
isol
genotyp
use
enterobacteri
repetit
intergen
consensuspcr
cluster
analys
alongsid
previous
characteris
panel
australian
share
p
aeruginosa
continu
variabl
report
mean
sd
binari
variabl
frequenc
percentag
analys
perform
use
test
oneway
mixedeffect
analysi
varianc
subject
random
factor
follow
least
signific
differ
procedur
repeat
estim
intraclass
correl
use
twoway
mix
effect
analysi
varianc
cfu
data
transform
log
mean
ci
back
transform
origin
unit
eas
interpret
also
perform
sensit
analysi
account
potenti
stack
organ
cascad
impactor
see
onlin
supplementari
method
p
aeruginosa
decay
time
assess
use
durat
rig
data
min
halflif
airborn
p
aeruginosa
estim
slope
decay
curv
model
see
onlin
supplementari
method
estim
rel
effect
ventil
airborn
biolog
decay
p
aeruginosa
remov
differ
healthcar
set
includ
studi
ventil
rate
express
standard
unit
air
chang
per
hour
ach
describ
mani
time
volum
air
equal
volum
room
enter
hour
subject
well
match
age
sex
height
cf
lower
weight
bodi
mass
index
lung
function
tabl
subject
complet
cough
manoeuvr
safe
four
patient
cf
studi
pulmonari
exacerb
within
cf
group
signific
chang
spirometri
studi
day
intraclass
correl
coeffici
ci
similarli
total
cfu
p
aeruginosa
cough
aerosol
cough
count
log
p
aeruginosa
sputum
concentr
within
subject
highli
repeat
see
onlin
supplementari
tabl
eighteen
patient
cf
produc
sputum
one
provid
cough
swab
tabl
p
aeruginosa
isol
yield
least
one
mucoid
isol
sputum
p
aeruginosa
concentr
rang
cfuml
genotyp
analysi
reveal
strain
share
commonli
within
australian
cf
seven
uniqu
strain
five
patient
harbour
two
differ
strain
organ
cultur
detail
tabl
p
aeruginosa
cultur
cough
aerosol
patient
cf
control
viabl
p
aeruginosa
isol
distanc
cf
group
figur
aerosolis
p
aeruginosa
remain
viabl
min
subject
durat
experi
figur
viabl
p
aeruginosa
isol
cultur
particl
tabl
strain
cultur
cough
aerosol
genotyp
indistinguish
isol
respiratori
sampl
patient
stenotrophomona
maltophilia
arxula
adeninivoran
also
cultur
cough
aerosol
sputum
two
patient
respiratori
pathogen
cultur
sputum
isol
cough
aerosol
p
aeruginosa
microb
identifi
cough
aerosol
isol
surfac
swab
blank
aerosol
sampl
taken
studi
see
onlin
supplementari
method
mark
intersubject
heterogen
seen
total
number
viabl
p
aeruginosa
cultur
cough
aerosol
figur
see
onlin
supplementari
tabl
measur
p
aeruginosa
cfu
decreas
distanc
aerosol
travel
age
time
cfu
significantli
higher
min
min
tabl
cfu
remain
significantli
higher
distanc
durat
correct
effect
stack
see
onlin
supplementari
tabl
distanc
durat
studi
strong
correl
seen
total
small
larg
fraction
cough
aerosol
posit
correl
found
sputum
aerosol
p
aeruginosa
cfu
distanc
durat
see
onlin
supplementari
tabl
studi
although
signific
correl
found
clinic
demograph
variabl
cough
aerosol
produc
either
studi
correl
variabl
unchang
measur
cfu
correct
stack
see
onlin
supplementari
tabl
influenc
biolog
decay
room
ventil
p
aeruginosa
cough
aerosol
model
see
onlin
supplementari
method
environment
condit
durat
rig
similar
aircondit
clinic
set
number
viabl
p
aeruginosa
cough
aerosol
follow
exponenti
decay
halflif
min
ci
min
room
ventil
remov
addit
viabl
p
aeruginosa
becam
domin
mechan
remov
ventil
rate
biolog
decay
rate
cough
aerosol
ie
approxim
ach
figur
show
time
taken
achiev
reduct
airborn
p
aeruginosa
follow
departur
sourc
patient
includ
combin
effect
biolog
decay
room
ventil
ach
viabl
airborn
p
aeruginosa
remov
approxim
min
ci
min
decreas
ventil
rate
increas
approxim
min
ci
min
ach
min
ci
min
ach
crossinfect
patient
cf
advers
affect
health
outcom
occur
transmiss
pathway
involv
remain
uncertain
shown
patient
cf
produc
aerosol
contain
viabl
p
aeruginosa
cough
particl
within
respir
rang
persist
distanc
time
provid
potenti
vehicl
airborn
transmiss
patient
mark
intersubject
heterogen
aerosol
product
observ
suggest
patient
may
superspread
p
aeruginosa
final
sputum
p
aeruginosa
concentr
strong
predictor
viabl
cough
aerosol
concentr
evid
highli
preval
share
p
aeruginosa
strain
within
cf
popul
suggest
persontoperson
use
air
sampl
equip
clinic
set
viabl
p
aeruginosa
demonstr
close
patient
share
strain
p
aeruginosa
clinic
signific
find
unclear
led
us
studi
size
distribut
cough
aerosol
previous
demonstr
p
aeruginosa
present
aerosol
gener
howev
unabl
determin
far
aerosol
travel
durat
remain
viabl
airborn
phase
vitro
aerosol
product
system
demonstr
artifici
produc
p
aeruginosa
aerosol
surviv
min
surviv
greater
mucoid
p
present
studi
confirm
aerosol
produc
cough
infect
patient
contain
viabl
p
aeruginosa
travel
stay
suspend
least
min
data
add
exist
evid
airborn
transmiss
like
play
role
patient
cf
acquir
p
aeruginosa
studi
demonstr
droplet
nuclei
gener
cough
contain
viabl
p
aeruginosa
small
enough
stay
airborn
extend
period
long
distanc
also
well
within
size
rang
deposit
within
tracheobronchi
tree
follow
droplet
effici
dissemin
locat
far
origin
mechan
room
air
ventil
system
often
recircul
air
use
heat
cool
role
room
ventil
potenti
airborn
transmiss
microb
tuberculosi
measl
sarscoronaviru
varicella
zoster
well
publish
guidelin
ventil
hospit
suggest
ach
fresh
ie
nonrecircul
air
requir
clinic
room
gener
ward
ach
recommend
procedur
room
ach
need
isol
previous
publish
result
measur
ach
variou
clinic
locat
within
tpch
found
meet
exceed
recommend
level
case
extrem
exampl
almost
ach
isol
room
emerg
howev
data
present
studi
suggest
clinic
room
recommend
two
ach
may
requir
almost
hour
patient
harbour
p
aeruginosa
leav
room
viabl
bacteria
remov
air
see
onlin
supplementari
method
data
substanti
implic
cf
infect
control
practic
model
suggest
increas
room
ventil
provid
benefit
howev
time
requir
remov
potenti
infecti
aerosol
still
exce
min
despit
substanti
increas
ach
figur
new
paradigm
may
need
employ
within
cf
centr
advanc
ventil
ultraviolet
germicid
irradi
uvgi
techniqu
achiev
infect
control
done
tb
studi
sever
import
limit
infecti
inoculum
requir
establish
p
aeruginosa
infect
cf
unknown
may
vari
thu
imposs
estim
extent
viabl
aerosol
p
aeruginosa
need
remov
elimin
risk
infect
suscept
patient
mani
cf
clinic
set
contact
droplet
infect
control
measur
implement
reduc
rate
share
p
aeruginosa
strain
infect
report
centr
employ
strict
cohort
segreg
base
upon
molecular
type
therefor
remain
uncertain
whether
simpler
measur
suffici
prevent
airborn
transmiss
also
consid
strict
segreg
larg
patient
cohort
attend
major
cf
centr
alway
studi
includ
small
number
older
patient
chronic
p
aeruginosa
infect
moder
sever
airflow
obstruct
thu
comment
viabl
aerosol
product
cough
younger
healthier
patient
transient
p
aeruginosa
infect
addit
use
cultur
media
select
aerob
gramneg
bacteria
provid
data
microb
includ
staphylococcu
aureu
nontubercul
mycobacteria
respiratori
futur
studi
use
select
media
determin
viabil
microorgan
cough
aerosol
requir
due
bactericid
effect
also
possibl
bacitracin
use
cultur
media
reduc
recoveri
p
aeruginosa
organ
final
model
data
assum
room
air
perfectli
mix
rare
case
estim
time
taken
remov
viabl
p
aeruginosa
clinic
room
may
overestim
underestim
realworld
scenario
see
onlin
supplementari
method
present
studi
use
bacteri
infect
patient
cf
demonstr
potenti
aerosol
transmiss
healthcar
set
add
studi
suggest
similar
mechan
tuberculosi
b
pertussi
nonhuman
primat
result
provid
evid
challeng
dogma
cf
bacteri
pathogen
within
droplet
nuclei
limit
surviv
air
inde
airborn
transmiss
may
import
mechan
crossinfect
within
cf
commun
previous
consid
case
furthermor
data
add
controversi
gener
current
usa
cf
foundat
guidelin
one
person
cf
attend
cf
foundationsponsor
cf
centresponsor
recommend
strongli
oppos
adult
summari
studi
indic
patient
cf
harbour
p
aeruginosa
cough
produc
aerosol
contain
viabl
organ
capabl
travel
persist
air
min
data
challeng
current
cf
infect
control
guidelin
remain
place
mani
part
world
includ
separ
patient
prevent
crossinfect
respiratori
consequ
studi
transmiss
need
infect
control
practic
recommend
current
cf
commun
may
need
reevalu
